SpringWorks Therapeutics, Inc. (SWTX) has 20 tenedores institucionales e internos conocidos registrados. El mayor tenedor es OrbiMed Capital GP VI LLC con 5,753,739 acciones. Otros tenedores destacados incluyen ORBIMED ADVISORS LLC y Bain Capital Life Sciences Investors, LLC.
En los últimos 12 meses, los internos han realizado 6 transacciones en SWTX acciones — 6 compras (valoradas en RSU Award) y 0 ventas (valoradas en RSU Award). Las compras internas han superado las ventas durante este período, lo que puede señalar confianza en las perspectivas de la empresa.
SWTX Participación de Insiders
Principal Titular
OrbiMed Capital GP VI LLC
5,753,739 acciones
Compras (12 meses)
6
$0.00 valor
Ventas (12 meses)
0
$0.00 valor
Actividad de Transacciones (12 meses)
Principales Titulares Internos
| # |
Nombre |
Cargo |
Acciones en Propiedad |
Última Declaración |
Tamaño Relativo |
| 1 |
Orbimed Capital Gp Vi Llc |
Director |
5,753,739 |
2022-08-10 |
|
| 2 |
Orbimed Advisors Llc |
10 Percent Owner |
5,599,842 |
2022-09-14 |
|
| 3 |
Bain Capital Life Sciences Investors, Llc |
10 Percent Owner |
4,831,307 |
2021-08-12 |
|
| 4 |
Islam Saqib |
Chief Executive Officer |
1,003,869 |
2025-03-05 |
|
| 5 |
Edris Badreddin |
Chief Operating Officer |
169,712 |
2025-03-05 |
|
| 6 |
Squinto Stephen P |
Director |
131,652 |
2022-05-20 |
|
| 7 |
Lynch Daniel |
Director |
93,004 |
2025-05-15 |
|
| 8 |
Ashar Bhavesh |
Chief Commercial Officer |
62,053 |
2025-02-24 |
|
| 9 |
Smith L. Mary |
Chief Development Officer |
60,000 |
2024-01-08 |
|
| 10 |
Cassidy James |
Chief Medical Officer |
50,615 |
2025-01-14 |
|
| 11 |
Austin Maury |
CFO |
50,000 |
2005-05-09 |
|
| 12 |
Burgess Michael F. |
Head of Research & Development |
49,584 |
2022-07-20 |
|
| 13 |
Renstrup Jens |
Chief Medical Officer |
48,600 |
2021-01-11 |
|
| 14 |
Weinstein Herschel S |
General Counsel & Secretary |
35,431 |
2025-01-14 |
|
| 15 |
Perier Francis I Jr |
Chief Financial Officer |
34,419 |
2025-01-14 |
|
| 16 |
Pichl Daniel |
Chief People Officer |
31,250 |
2025-02-12 |
|
| 17 |
Alban Carlos |
Director |
28,861 |
2025-05-15 |
|
| 18 |
Francis Perier I Jr |
Chief Financial Officer |
26,963 |
2022-01-11 |
|
| 19 |
Lewis-hall Freda C |
Director |
24,727 |
2025-05-15 |
|
| 20 |
Fuhrman Alan |
Director |
24,727 |
2025-05-15 |
|
Transacciones Recientes (últimos 12 meses)
| Fecha |
Nombre |
Cargo |
Tipo |
Acciones |
Precio |
Valor |
| 2025-05-14 |
Hambleton Julie |
Director |
Concesión de RSU |
10,060 |
- |
- |
| 2025-05-14 |
Alban Carlos |
Director |
Concesión de RSU |
10,060 |
- |
- |
| 2025-05-14 |
Lewis-hall Freda C |
Director |
Concesión de RSU |
10,060 |
- |
- |
| 2025-05-14 |
Mackay Martin |
Director |
Concesión de RSU |
10,060 |
- |
- |
| 2025-05-14 |
Fuhrman Alan |
Director |
Concesión de RSU |
10,060 |
- |
- |
| 2025-05-14 |
Lynch Daniel |
Director |
Concesión de RSU |
10,060 |
- |
- |
